Pediatric Cardiology

, Volume 26, Issue 6, pp 768–771 | Cite as

Steroid Therapy and Cardiac Function in Duchenne Muscular Dystrophy

  • L.W. MarkhamEmail author
  • R.L. Spicer
  • P.R. Khoury
  • B.L. Wong
  • K.D. Mathews
  • L.H. Cripe


Duchenne muscular dystrophy leads to progressive deterioration in skeletal and cardiac muscle function. Steroids prolong ambulation and improve respiratory muscle strength. The authors hypothesized that steroid treatment would stabilize cardiac muscle function. Echocardiograms performed from 1997 to 2004 for 111 subjects 21 years of age or younger with Duchenne muscular dystrophy were restrospectively reviewed. The medical record was reviewed for steroid treatment. Untreated and steroids-treated subjects did not differ in age, height, weight, body mass index, systolic and diastolic blood pressure, or left ventricular mass. The shortening fraction was lower in the untreated group. Of those treated, 29 received prednisone and 19 received deflazacort. There was no difference in the shortening fraction between the two treated subgroups. Treated subjects not receiving steroids still had a normal shortening fraction, which was no different from the shortening fraction of those still receiving treatment. As compared with the treated subjects, the untreated subjects 10 years of age or younger were 4.4 times more likely to have a shortening fraction less than< 28% (p = 0.03), and the untreated subjects older than 10 years were 15.2 times more likely to have a shortening fraction less than< 28% (p < 0.01). This retrospective study suggests that the progressive decline in cardiac function of patients with Duchenne muscular dystrophy can be altered by steroid treatment. The effect appears to be sustained beyond the duration of treatment and independent of steroid type.


Cardiomyopathy Duchenne muscular dystrophy Steroids 


  1. 1.
    Biggar, WD, Gingras, M, Fehlings, DL, Harris, VA, Steele, CA 2001Deflazacort treatment of Duchenne muscular dystrophyJ Piediatr1384550Google Scholar
  2. 2.
    Boland, BJ, Silbert, PL, Groover, RV, Wollan, PC, Silverstein, MD 1996Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophyPediatr Neurol14712CrossRefPubMedGoogle Scholar
  3. 3.
    Brooke, MH, Fenichel, GM, Griggs, RC, Mendell, JR, Moxley, RT,III,  et al. 1987Clinical investigation of Duchenne muscular dystrophy: Interesting results in a trial of prednisoneArch Neurol44812817PubMedGoogle Scholar
  4. 4.
    Bushby, K, Muntoni, F, Urtizberea, A, Hughes, R, Griggs, R 2004Treatment of Duchenne muscular dystrophy. Defining the gold standards of management in the use of corticosteroids. Report of the 124th ENMC International WorkshopNeuromuscul Disord14526534PubMedGoogle Scholar
  5. 5.
    Connolly, AM, Schierbecker, J, Renna, R, Florence, J 2002High-dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophyNeuromuscul Disord12917925PubMedGoogle Scholar
  6. 6.
    DeSilva, S, Drachman, DB, Mellits, D, Kuncl, RW 1987Prednisone treatment in Duchenne muscular dystrophy: Long-term benefitArch Neurol44818822PubMedGoogle Scholar
  7. 7.
    Devereux, RB, Alonso, DR, Lutas, EM,  et al. 1986Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsAm J Cardiol57450458PubMedGoogle Scholar
  8. 8.
    D’Orsogna, L, O’Shea, JP, Mllier, G 1988 Cardiomyopathy of Duchenne muscular dystrophyPediatr Cardiol96205213Google Scholar
  9. 9.
    Gutgesell, HP,  et al. 1977Evaluation of left ventricular size and function by echocardiography: Results in normal childrenCirculation56457462PubMedGoogle Scholar
  10. 10.
    Heymsfield, SB, McNish, T, Perkins, JV, Felner, JM 1978Sequence of cardiac changes in Duchenne muscular dystrophyAm Heart J95283294PubMedGoogle Scholar
  11. 11.
    Manning, GW, Cropp, CJ 1958Electrocardiogram in progressive muscular dystrophyBr Heart J20416420PubMedGoogle Scholar
  12. 12.
    Manzur, AY, Kuntzer, T, Pike, M, Swan, A 2004Glucocorticoid corticosteroids for Duchenne muscular dystrophyCochrane Database Syst Rev2CD003725PubMedGoogle Scholar
  13. 13.
    Mesa, LE, Dubrovsky, AL, Corderi, J, Marco, P, Flores, D 1991Steroids in Duchenne muscular dystrophy: Deflazacort trialNeuromuscul Disord1261266PubMedGoogle Scholar
  14. 14.
    Perloff, JK, Leon, AC,Jr, O’Doherty, D 1996The cardiomyopathy of progressive muscular dystrophyCirculation33625648Google Scholar
  15. 15.
    Perloff, JK, Roberts, WC, deLeon, AC, O’Doherty, D 1967Distinctive electrocardiography of Duchenne’s progressive muscular dystrophy: An electrocardiographic–pathologic correlative studyAm J Med42179188CrossRefPubMedGoogle Scholar
  16. 16.
    Sasaki, K, Sakata, K, Kachi, E, Hirata, S, Ishihara, T, Ishikawa, K 1998Sequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: A two-dimensional echocardiographic studyAm Heart J135937944PubMedGoogle Scholar
  17. 17.
    Schott, J, Jacobi, M, Wald, MA 1955Electrocardiographic patterns in the differential diagnosis of progressive muscular dystrophyAm J Med Sci229517524PubMedGoogle Scholar
  18. 18.
    Silversides, CK, Webb, GD, Harris, VA, Biggar, WD 2003Effects of deflazacort on left ventricular functions in patients with Duchenne muscular dystrophyAm J Cardiol91769772PubMedGoogle Scholar
  19. 19.
    Wahi, PL, Bhargava, KC, Mohindra, S 1971Cardiorespiratory changes in progressive muscular dystrophyBr Heart J33533537PubMedGoogle Scholar
  20. 20.
    Wong, BL, Christopher, C 2002Corticosteroids in Duchenne muscular dystrophy: A reappraisalJ Child Neurol17183190PubMedGoogle Scholar
  21. 21.
    Yilmaz, O, Karaduman, A, Topaloglu, H 2004Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosisEur J Neurol11541544CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • L.W. Markham
    • 1
    Email author
  • R.L. Spicer
    • 1
  • P.R. Khoury
    • 1
  • B.L. Wong
    • 2
  • K.D. Mathews
    • 3
  • L.H. Cripe
    • 1
  1. 1.Department of Pediatrics, Division of Pediatric CardiologyCincinnati Children’s Hospital Medical CenterCincinnatiUSA
  2. 2.Department of NeurologyCincinnati Children’ Hospital Medical CenterCincinnatiUSA
  3. 3.Department of Pediatrics and NeurologyUniversity of IowaIowa cityUSA

Personalised recommendations